Publicaciones en las que colabora con SALETA VAZQUEZ RODRIGUEZ (27)

2018

  1. Development of 8-pyridopyrimidinone-based covalent inhibitors of KDM5B

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

  2. Development of KDM5 covalent inhibitors as chemical probes

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

2017

  1. Heterocyclic antioxidants in nature: Coumarins

    Current Organic Chemistry, Vol. 21, Núm. 4, pp. 311-324

  2. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 2, pp. 621-632

2016

  1. Facing chagas' disease: Trypanocidal properties of new coumarinchalcone scaffolds

    Medicinal Chemistry, Vol. 12, Núm. 6, pp. 537-543

  2. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core

    MedChemComm, Vol. 7, Núm. 5, pp. 845-852

2015

  1. Bioactive coumarins from marine sources: Origin, structural features and pharmacological properties

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1755-1766

  2. Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis

    Bioorganic and Medicinal Chemistry, Vol. 23, Núm. 21, pp. 7045-7052

  3. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold

    Bioorganic Chemistry, Vol. 61, pp. 1-6

  4. Interest of antioxidant agents in parasitic diseases. The case study of coumarins

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 9, pp. 850-856

  5. Potential pharmacological uses of chalcones: A patent review (from June 2011-2014)

    Expert Opinion on Therapeutic Patents, Vol. 25, Núm. 3, pp. 351-366

  6. Study of coumarin-resveratrol hybrids as potent antioxidant compounds

    Molecules, Vol. 20, Núm. 2, pp. 3290-3308

  7. Synthesis and pharmacological activities of non-flavonoid chromones: A patent review (from 2005 to 2015)

    Expert Opinion on Therapeutic Patents, Vol. 25, Núm. 11, pp. 1285-1304

2013

  1. 3-(4-Methoxybenzoyl)-6-nitrocoumarin

    Acta Crystallographica Section E: Structure Reports Online, Vol. 69, Núm. 3

  2. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists

    Journal of Pharmacy and Pharmacology, Vol. 65, Núm. 5, pp. 697-703

  3. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 13, pp. 3900-3906

  4. Synthesis and electrochemical and biological studies of novel coumarin-chalcone hybrid compounds

    Journal of Medicinal Chemistry, Vol. 56, Núm. 15, pp. 6136-6145

  5. Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives

    Future Medicinal Chemistry, Vol. 5, Núm. 16, pp. 1911-1922

  6. Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents

    Molecules, Vol. 18, Núm. 2, pp. 1394-1404

  7. Synthesis of coumarin-chalcone hybrids and evaluation of their antioxidant and trypanocidal properties

    MedChemComm, Vol. 4, Núm. 6, pp. 993-1000